🇺🇸 FDA
Patent

US 10888581

Chimeric antigen receptor and methods of use thereof

granted A61KA61K2039/505A61K2239/23

Quick answer

US patent 10888581 (Chimeric antigen receptor and methods of use thereof) held by The Regents of the University of California expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K2039/505, A61K2239/23, A61K2239/24, A61K2239/31